TuHURA Biosciences, Inc.
HURA
$1.81
-$0.03-1.63%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -59.44% | -117.08% | -- | -- | -- |
| Total Depreciation and Amortization | -50.81% | -29.93% | -- | -- | -- |
| Total Amortization of Deferred Charges | -84.59% | 89.53% | -- | -- | -- |
| Total Other Non-Cash Items | 349.93% | 294.71% | -- | -- | -- |
| Change in Net Operating Assets | -324.21% | 889.65% | -- | -- | -- |
| Cash from Operations | -62.76% | -40.94% | -- | -- | -- |
| Capital Expenditure | 8.53% | 8.53% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -39.70% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 59.55% | -9,510.76% | -- | -- | -- |
| Total Debt Issued | -100.00% | -56.33% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 123.83% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -92.77% | -232.84% | -- | -- | -- |
| Cash from Financing | -72.47% | 0.35% | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -208.70% | -145.98% | -- | -- | -- |